AbbVie Inc. (ABBV) Presents at Leerink Global Healthcare Conference 2026 Transcript

Understand this faster with AI
SA Transcripts158.9K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call AbbVie Inc. (ABBV) Leerink Global Healthcare Conference 2026 March 10, 2026 11:20 AM EDT Company Participants Scott Reents - Executive VP & CFORoopal Thakkar - Executive VP of Research & Development and Chief Scientific Officer Conference Call Participants David Risinger - Leerink Partners LLC, Research Division Presentation David RisingerLeerink Partners LLC, Research Division So good morning, everyone. My name is Dave Risinger. I'm very pleased to host a couple of senior executives from AbbVie. So immediately to my left is the CSO, Roopal Thakkar, and to his left is the CFO, Scott Reents. And very much appreciate you joining the Leerink Global Healthcare Conference. Question-and-Answer Session David RisingerLeerink Partners LLC, Research Division Maybe, Scott, you can kick us off with some high-level remarks on the company's growth prospects and how we should think about the margin profile in coming years? Scott ReentsExecutive VP & CFO Yes, of course, happy to do that. First, thank you very much for having us down and beautiful weather. So it's never hard to come down here from Chicago at this time of the year. So I appreciate you having us. When we think about the business, I think we've been pretty -- we've talked a lot about the prospects. Obviously, we're excited the way 2025 performed, the momentum coming in. We're excited with our guidance of $67 billion in 2026. But really, when we look at the business, we have the portfolio of assets in place today on market derisked, and we've talked about this a lot, driving high single-digit growth through the decade. We're very confident and continue to be very confident in doing that as well as a clear line of sight to robust growth into the next decade as well. So we have what we need to continue to grow. When you think about that growth and what's going to drive that growth, certainly, SKYRIZI
Source Information
Discussion
0 professional contributions
Sign in to join this professional discussion.
Be the first to add a constructive contribution.
